Literature DB >> 24782551

A case of drug-induced interstitial pneumonia potentially related to quetiapine (seroquel) therapy for behavioral and psychological symptoms.

Se-Jin Kim1, Sang-Don Han2, Jung Yeon Lee3, Gyu Rak Chon4.   

Abstract

Quetiapine is regarded as an effective and safe treatment for delirium. An 82-year-old man presented with a 1-week history of violent behavior and dizziness accompanied by weakness on the left side of his body. He was diagnosed with acute cerebral cortical infarction and delirium associated with alcohol abuse. After quetiapine treatment, he complained of fever and coughed up sputum, whereas his aggressive behavior improved. His symptoms persisted despite empirical antibiotic treatment. All diagnostic tests for infectious causes were negative. High-resolution computed tomography revealed bilateral consolidations and ground-glass opacities with predominantly peribronchial and subpleural distributions. The primary differential diagnosis was drug-associated interstitial lung disease, and therefore, we discontinued quetiapine and began methylprednisolone treatment. His symptoms and radiologic findings significantly improved after receiving steroid therapy. We propose that clinicians need to be aware of the possibility that quetiapine is associated with lung injury.
Copyright © 2014 by Daedalus Enterprises.

Entities:  

Keywords:  alcohol abuse; interstitial pneumonia; quetiapine

Mesh:

Substances:

Year:  2014        PMID: 24782551     DOI: 10.4187/respcare.02977

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  2 in total

Review 1.  Biological substantiation of antipsychotic-associated pneumonia: Systematic literature review and computational analyses.

Authors:  Janet Sultana; Marco Calabró; Ricard Garcia-Serna; Carmen Ferrajolo; Concetta Crisafulli; Jordi Mestres; Gianluca Trifirò'
Journal:  PLoS One       Date:  2017-10-27       Impact factor: 3.240

2.  Quetiapine-related acute lung injury: A case report.

Authors:  Yi-Xia Huang; Guo-Xin He; Wen-Jing Zhang; Bo-Wu Li; Hai-Xu Weng; Wen-Chao Luo
Journal:  World J Clin Cases       Date:  2022-03-06       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.